Skip to main content
Fig. 6 | World Journal of Surgical Oncology

Fig. 6

From: Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer

Fig. 6

a Forest plots of the pooled RR for the sub-analysis of anthracycline effect in DFS between sequential and concurrent regimens. The results indicated that there was a significantly better DFS in patients with doxorubicin and a taxane in the sequential group (RR, 0.91; 95% CI, 0.86-0.97, P = 0.002). b Forest plots of the pooled RR for the sub-analysis of anthracycline effect in OS between sequential and concurrent regimens. The results indicated that there was a significantly better OS in patients with doxorubicin and a taxane in the sequential group (RR, 0.92; 95% CI, 0.84-0.99, P = 0.03)

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us